We are live on
!
Find out more
US Bancorp Portfolio holdings
AUM
$82.4B
1-Year Est. Return
19.69%
This Fund
S&P 500
This Quarter
Est. Return
+8.01%
1 Year Est. Return
+19.69%
3 Year Est. Return
+59.6%
5 Year Est. Return
+69.89%
10 Year Est. Return
+246.63%
AUM
$39.1B
AUM Growth
+$2.42B
(+6.6%)
Cap. Flow
-$248M
Cap. Flow
% of AUM
-0.63%
Top 10 Holdings %
Top 10 Hldgs %
22.64%
Holding
3,845
New
218
Increased
1,110
Reduced
1,483
Closed
148
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell Mid-Cap ETF
IWR
|
+$45.6M |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$40.7M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$38.8M |
| 4 |
iShares S&P 500 Value ETF
IVE
|
+$35.5M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$34.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$80.2M |
| 2 |
Copart
CPRT
|
+$55.9M |
| 3 |
US Bancorp
USB
|
+$47.8M |
| 4 |
IBDK
iShares iBonds Dec 2019 Term Corporate ETF
IBDK
|
+$25.8M |
| 5 |
iShares Floating Rate Bond ETF
FLOT
|
+$17.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.27% |
| 2 | Financials | 10.78% |
| 3 | Industrials | 9.91% |
| 4 | Healthcare | 9.19% |
| 5 | Consumer Staples | 6.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Danaher
DHR
$135B
| $36.4M | 0.09% |
267,762
-2,153
| -0.8% | -$272K |
|
177
Vanguard S&P 500 ETF
VOO
$967B
| $36M | 0.09% |
121,699
+2,122
| +2% | +$600K |
|
178
TSMC
TSM
$2.16T
| $35.8M | 0.09% |
616,943
-46,117
| -7% | -$2.45M |
|
179
Intuit
INTU
$77B
| $35.3M | 0.09% |
134,923
-662
| -0.5% | -$173K |
|
180
Truist Financial
TFC
$62.5B
| $35.1M | 0.09% |
623,553
+250,137
| +67% | +$13.5M |
|
181
Xcel Energy
XEL
$50.4B
| $35.1M | 0.09% |
552,228
-3,761
| -0.7% | -$235K |
|
182
Vanguard Short-Term Bond ETF
BSV
$44.6B
| $35M | 0.09% |
434,290
+34,110
| +9% | +$2.75M |
|
|
IBDL
183
DELISTED
iShares iBonds Dec 2020 Term Corporate ETF
IBDL
| $35M | 0.09% |
1,382,454
+305,342
| +28% | +$7.73M |
|
184
Sherwin-Williams
SHW
$76.6B
| $34.8M | 0.09% |
178,830
-1,197
| -0.7% | -$228K |
|
185
Pentair
PNR
$10B
| $34.4M | 0.09% |
748,866
-98,895
| -12% | -$4.18M |
|
186
Vanguard Growth ETF
VUG
$217B
| $34.3M | 0.09% |
1,129,050
+55,818
| +5% | +$1.61M |
|
187
Duke Energy
DUK
$101B
| $34.2M | 0.09% |
374,786
-3,781
| -1% | -$347K |
|
188
Enbridge
ENB
$123B
| $33.9M | 0.09% |
851,437
-107,095
| -11% | -$4M |
|
189
Phillips 66
PSX
$83B
| $33.6M | 0.09% |
301,977
-7,621
| -2% | -$856K |
|
190
Five Below
FIVE
$11.1B
| $33.5M | 0.09% |
261,963
+16,283
| +7% | +$2.04M |
|
191
RingCentral
RNG
$3.24B
| $33.3M | 0.09% |
197,230
-6,448
| -3% | -$1.06M |
|
192
CSX Corp
CSX
$98.1B
| $33.2M | 0.08% |
1,374,948
-12,255
| -0.9% | -$290K |
|
193
Estee Lauder
EL
$28.9B
| $33.1M | 0.08% |
160,264
-13,167
| -8% | -$2.56M |
|
194
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.9B
| $32.8M | 0.08% |
286,424
-40,015
| -12% | -$4.52M |
|
195
Western Digital
WDC
$192B
| $32.8M | 0.08% |
683,189
-123,244
| -15% | -$5.14M |
|
196
Stryker
SYK
$122B
| $32.7M | 0.08% |
155,820
-948
| -0.6% | -$197K |
|
197
Cigna
CI
$75.7B
| $32.7M | 0.08% |
159,921
-6,485
| -4% | -$1.19M |
|
198
TJX Companies
TJX
$170B
| $32.3M | 0.08% |
528,292
-4,803
| -0.9% | -$284K |
|
199
Eaton
ETN
$161B
| $32M | 0.08% |
337,818
-2,329
| -0.7% | -$207K |
|
200
Dow Inc
DOW
$22.3B
| $31.9M | 0.08% |
582,244
-10,449
| -2% | -$540K |
|
Similar funds
US Bancorp's Q4 2019 Portfolio in Review
As of Q4 2019, US Bancorp held 3,845 positions worth $39.1B, up 6.6% from $36.7B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
US Bancorp's Q4 2019 filing shows 218 new, 1,110 increased, 1,483 reduced and 148 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 611,031 shares worth $1.84M. The largest sale was Celgene Corp, an estimated $80.2M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Industrials.
- US Bancorp's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 611,031 shares worth $1.84M.
- US Bancorp added most to iShares Russell Mid-Cap ETF in Q4 2019, an estimated $45.6M increase.
- US Bancorp's biggest Q4 2019 reduction was Copart, cutting an estimated $55.9M.
- US Bancorp fully exited Celgene Corp in Q4 2019, selling an estimated $80.2M.
- US Bancorp's ten largest holdings make up 23% of its $39.1B portfolio in Q4 2019.
- US Bancorp opened 218 new positions and closed 148 in Q4 2019.
- US Bancorp's portfolio value rose 6.6% quarter-over-quarter to $39.1B.
Based on US Bancorp's 13F filing for Q4 2019, filed 4 Feb 2020.